Skip to main content
Top
Published in: Supportive Care in Cancer 4/2018

01-04-2018 | Original Article

A discrete choice experiment to assess cancer patients’ preferences for when and how to make treatment decisions

Authors: Anne Herrmann, Rob Sanson-Fisher, Alix Hall, Laura Wall, Nicholas Zdenkowski, Amy Waller

Published in: Supportive Care in Cancer | Issue 4/2018

Login to get access

Abstract

Purpose

Cancer patients can be overwhelmed when being confronted with their diagnosis and treatment options. Such information is often provided during one consultation between the patient and treating clinician. In order to achieve optimal cancer care, there may be justification for alternative consultation styles. We assessed, in a sample of adult medical oncology patients, their preferences for (i) attending one 40-min consultation or two 20-min consultations and (ii) receiving written only or both written and online information, when making a cancer treatment decision.

Methods

This was a cross-sectional survey using a discrete choice design of 159 adult medical oncology patients presenting for their second or subsequent outpatient consultation. Participants were presented with a set of hypothetical scenarios and asked to indicate their most and least preferred scenario. The scenarios contained a caveat explaining that there would be no difference between the available treatment options in terms of when treatment would be initiated and the impact it would have on patients’ life expectancy.

Results

One hundred forty-seven patients completed the DCE. Of these, 70% (n = 103) preferred being provided with written and online information rather than just written information. This preference was statistically significant (p < 0.01). Fifty-nine percent (n = 86) of patients preferred two 20-min consultations over one 40-min consultation when making a treatment decision. Significantly, more patients preferred two shorter consultations rather than one longer consultation when this was combined with written and online information (p < 0.01).

Conclusion

When making a cancer treatment decision, clinicians should consider offering patients written and online information, combined with two shorter consultations.
Literature
1.
go back to reference Institute of Medicine (2001) Crossing the quality chasm: a new health system for the 21st century committee on quality of health care in America, Washington, DC Institute of Medicine (2001) Crossing the quality chasm: a new health system for the 21st century committee on quality of health care in America, Washington, DC
4.
go back to reference General Medical Council (2008) Consent: patients and doctors making decisions together. General Medical Council, Manchester General Medical Council (2008) Consent: patients and doctors making decisions together. General Medical Council, Manchester
5.
go back to reference Girgis A, Sanson-Fisher RW (1995) Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol 13(9):2449–2456CrossRefPubMed Girgis A, Sanson-Fisher RW (1995) Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol 13(9):2449–2456CrossRefPubMed
6.
9.
go back to reference Louviere JJ (2001) Choice experiments: an overview of concepts and issues. The choice modelling approach to environmental valuation. In: Bennett J, Blamey R (eds) The choice modelling approach to environmental valuation. Edward Elgar Publishing, Cheltenham, pp 13–36 Louviere JJ (2001) Choice experiments: an overview of concepts and issues. The choice modelling approach to environmental valuation. In: Bennett J, Blamey R (eds) The choice modelling approach to environmental valuation. Edward Elgar Publishing, Cheltenham, pp 13–36
17.
go back to reference Coulter A, Peto V, Doll H (1994) Patients’ preferences and general practitioners’ decisions in the treatment of menstrual disorders. Fam Pract 11(1):67–74CrossRefPubMed Coulter A, Peto V, Doll H (1994) Patients’ preferences and general practitioners’ decisions in the treatment of menstrual disorders. Fam Pract 11(1):67–74CrossRefPubMed
22.
go back to reference Thaker DA, Monypenny R, Olver I, Sabesan S (2013) Cost savings from a telemedicine model of care in northern Queensland, Australia. Med J Aust 199(6):414–417CrossRefPubMed Thaker DA, Monypenny R, Olver I, Sabesan S (2013) Cost savings from a telemedicine model of care in northern Queensland, Australia. Med J Aust 199(6):414–417CrossRefPubMed
29.
go back to reference de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21(2):145–172CrossRefPubMed de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21(2):145–172CrossRefPubMed
30.
go back to reference Telser H, Zweifel P (2007) Validity of discrete-choice experiments evidence for health risk reduction. Applied Econ 39(1):69–78CrossRef Telser H, Zweifel P (2007) Validity of discrete-choice experiments evidence for health risk reduction. Applied Econ 39(1):69–78CrossRef
Metadata
Title
A discrete choice experiment to assess cancer patients’ preferences for when and how to make treatment decisions
Authors
Anne Herrmann
Rob Sanson-Fisher
Alix Hall
Laura Wall
Nicholas Zdenkowski
Amy Waller
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3944-9

Other articles of this Issue 4/2018

Supportive Care in Cancer 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine